We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Sanofi and Regeneron IL-6 Receptor Antibody Gets Approval In Canada

News   Feb 06, 2017 | Original Story From Sanofi

 
Sanofi and Regeneron IL-6 Receptor Antibody Gets Approval In Canada
 
 
 

RELATED ARTICLES

Illuminating Potentially Fatal Complication of Hepatitis B

News

Hepatitis B virus (HBV) - associated acute liver failure results from an uncommon encounter between a highly mutated HBV variant and an unusual immune response.

READ MORE

Revealed: How Deadly Pneumococcus Suppresses Immune Defenses

News

Scientists have discovered a new and important function of a toxin produced by disease-causing bacteria that could have significant implications for future vaccine design.

READ MORE

The Role of Oligodendrocytes in MS

News

Mapping of a certain group of cells, known as oligodendrocytes, in the central nervous system of a mouse model of multiple sclerosis (MS), shows that they might have a significant role in the development of the disease. The discovery can lead to new therapies targeted at other areas than just the immune system.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE